Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Vamorolone[1] Vamorolone (Vamorolone)[1] Vamorolone (Vamorolone) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 97, 113 💬
2Vamorolone 0.25 mg/day/day[1] Vamorolone (Vamorolone)[1] Vamorolone (Vamorolone) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
3Vamorolone 0.25 mg/kg/day[1] Vamorolone (Vamorolone)[1] Vamorolone (Vamorolone) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
4Vamorolone 0.75 mg/day/day[1] Vamorolone (Vamorolone)[1] Vamorolone (Vamorolone) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
5Vamorolone 0.75 mg/kg/day[1] Vamorolone (Vamorolone)[1] Vamorolone (Vamorolone) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
6Vamorolone 2.0 mg/day/day[1] Vamorolone (Vamorolone)[1] Vamorolone (Vamorolone) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
7Vamorolone 2.0 mg/kg/day[1] Vamorolone (Vamorolone)[1] Vamorolone (Vamorolone) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
8Vamorolone 4% suspension for oral dosing[1] Vamorolone (Vamorolone)[1] Vamorolone (Vamorolone) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
9Vamorolone 6.0 mg/day/day[1] Vamorolone (Vamorolone)[1] Vamorolone (Vamorolone) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
10Vamorolone 6.0 mg/kg/day[1] Vamorolone (Vamorolone)[1] Vamorolone (Vamorolone) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬